Doxorubicin HCl by Hospira

Doxorubicin HCl by Hospira Uses, Dosage, Side Effects, Food Interaction and all others data.

Doxorubicin HCl by Hospira is a cytotoxic anthracycline antibiotic. The cytotoxic action results from its binding to DNA and inhibition of nucleic acid synthesis. Doxorubicin HCl by Hospira has been shown to produce regression in a variety of disseminated malignancies.

Doxorubicin HCl by Hospira is an antineoplastic in the anthracycline class. General properties of drugs in this class include: interaction with DNA in a variety of different ways including intercalation (squeezing between the base pairs), DNA strand breakage and inhibition with the enzyme topoisomerase II. Most of these compounds have been isolated from natural sources and antibiotics. However, they lack the specificity of the antimicrobial antibiotics and thus produce significant toxicity. The anthracyclines are among the most important antitumor drugs available. Doxorubicin HCl by Hospira is widely used for the treatment of several solid tumors while daunorubicin and idarubicin are used exclusively for the treatment of leukemia. Doxorubicin HCl by Hospira may also inhibit polymerase activity, affect regulation of gene expression, and produce free radical damage to DNA. Doxorubicin HCl by Hospira possesses an antitumor effect against a wide spectrum of tumors, either grafted or spontaneous. The anthracyclines are cell cycle-nonspecific.

Doxorubicin HCl by Hospira
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Doxorubicin HCl by Hospira
Availability	Prescription only
Generic	Doxorubicin
Doxorubicin Other Names	14-hydroxydaunomycin, 14-hydroxydaunorubicine, Doxorubicin, Doxorubicina, Doxorubicine, Doxorubicinum, Hydroxydaunorubicin
Related Drugs	prednisone, methotrexate, dexamethasone, Keytruda, Armour Thyroid, Arimidex, rituximab, carboplatin, pembrolizumab, fluorouracil
Type
Formula	C₂₇H₂₉NO₁₁
Weight	Average: 543.5193 Monoisotopic: 543.174060775
Protein binding	Doxorubicin and its major metabolite, doxorubicinol, is 74-76% bound to plasma protein. The extent to binding is independent of plasma concentration up to 1.1 mcg/mL. Doxorubicin does not cross the blood brain barrier.
Groups	Approved, Investigational
Therapeutic Class	Cytotoxic Chemotherapy
Manufacturer
Available Country	United States
Last Updated:	September 19, 2023 at 7:00 am

Uses

Doxorubicin HCl by Hospira is an anthracycline topoisomerase II inhibitor used for:

Ovarian cancer: After failure of platinum-based chemotherapy.
AIDS-related Kaposi’s Sarcoma: After failure of prior systemic chemotherapy or intolerance to such therapy.
Multiple Myeloma: In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy.

Doxorubicin HCl by Hospira is also used to associated treatment for these conditions: Acute Lymphoblastic Leukaemias (ALL), Acute Myeloblastic Leukemia, Advanced Endometrial Cancer, Advanced Soft Tissue Sarcoma, Bladder transitional cell carcinoma, Carcinoma, Bronchogenic, Gastric Carcinoma, Kaposi's Sarcoma AIDS Related, Lymphoma, Hodgkins, Malignant Lymphomas, Metastatic Breast Cancer, Multiple Myeloma (MM), Mycosis Fungoides (MF), Neuroblastomas, Ovarian Cancer Metastatic, Ovarian Carcinoma, Sarcoma, Bone, Sezary Syndrome, Soft Tissue Sarcoma (STS), Thyroid Carcinoma, Waldenström's Macroglobulinemia (WM), Wilms' tumor, Advanced Thymoma, Advanced uterine sarcoma

How Doxorubicin HCl by Hospira works

Doxorubicin HCl by Hospira has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Doxorubicin HCl by Hospira forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.

Dosage

Doxorubicin HCl by Hospira dosage

Administer Doxorubicin HCl by Hospira at an initial rate of 1 mg/min to minimize the risk of infusion reactions. If no infusion related reactions occur, increase rate of infusion to complete administration over 1 hour. Do not administer as bolus injection or undiluted solution.

Ovarian cancer: 50 mg/m2 IV every 4 weeks
AIDS-related Kaposi’s Sarcoma: 20 mg/m2 IV every 3 weeks
Multiple Myeloma: 30 mg/m2 IV on day 4 following bortezomib

Side Effects

Leucopenia, thrombocytopenia, nausea, vomiting, diarrhoea. Rarely facial flushing, rash, alopecia. Blurred vision, headache, seizures, paraesthesia, confusion, malaise, lethargy, skin pigmentation.

Toxicity

LD₅₀=21800 ug/kg (rat, subcutaneous)

Precaution

Elderly, children, hepatic impairment. Monitor blood counts and ECG.

Interaction

Doxorubicin HCl by Hospira interacts with a number of other drugs e.g. antibiotics (aminoglycosides), steroids, aminophylline and propranolol.

Food Interaction

Avoid St. John's Wort. This herb induces CYP3A4 metabolism, which may reduce the serum concentration of doxorubicin.
Exercise caution with grapefruit products. Grapefruit inhibits CYP3A4 metabolism, which may increase the serum concentration of doxorubicin.

Doxorubicin HCl by Hospira Drug Interaction

Moderate: aprepitant, aprepitant, pegfilgrastim, pegfilgrastim, ondansetron, ondansetronMinor: sulfamethoxazole / trimethoprim, sulfamethoxazole / trimethoprim, cyclophosphamide, cyclophosphamideUnknown: lorazepam, lorazepam, diphenhydramine, diphenhydramine, loratadine, loratadine, cyanocobalamin, cyanocobalamin, cholecalciferol, cholecalciferol

Doxorubicin HCl by Hospira Disease Interaction

Major: infections, cardiomyopathy, hepatic dysfunction, myelosuppression

Volume of Distribution

The distributive half-life is 5 minutes, which suggests that doxorubicin is rapidly taken up by tissue. Steady state volume of distribution = 809 to 1214 L/m2

Half Life

Terminal half life = 20 - 48 hours.

Clearance

324-809 mL/min/m2 [by metabolism and biliary excretion]
1088 mL/min/m2 [Men]
433 mL/min/m2 [Women]
1540 mL/min/m2 [children greater than 2 years of age receiving administration of 10 to 75 mg/m2 doses]
813 mL/min/m2 [infants younger than 2 years of age receiving administration of 10 to 75 mg/m2 doses]

Elimination Route

40% of the dose appears in bile in 5 days. 5-12% of the drug and its metabolites appears in urine during the same time period. <3% of the dose recovered in urine was doxorubicinol.

Pregnancy & Breastfeeding use

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).

Contraindication

Cardiac disease, neonates, pregnancy and lactation, prior irradiation to mediastinum. IM/SC admin. Severe myelosuppression due to previous treatment with antitumour agents or radiotherapy.

Special Warning

Hepatic Impairment-

serum-bilirubin: 12-30 mcg/ml: Half the normal dose;

serum-bilirubin: >30 mcg/ml: Quarter of the usual dose.

Acute Overdose

Acute overdosage may increase the toxic effects of mucositis, leukopenia and thrombocytopenia. Treatment includes hospitalisation of the severely myelosuppressed patient, antimicrobials, platelet transfusions and symptomatic treatment of mucositis. Use of haemopoietic growth factor (G-CSF, GM-CSF) may be considered. Cumulative dosage increases risk of cardiomyopathy and resultant congestive heart failure which may be managed with digitalis preparations, diuretics, and after load reducers such as ACE inhibitors.

Storage Condition

Powder for injection: Store at 15-30°C.

Solution for injection & liposomal formulations: Refrigerate at 2-8°C. Do not freeze.

Innovators Monograph

You find simplified version here Doxorubicin HCl by Hospira

Doxorubicin HCl by Hospira contains Doxorubicin see full prescribing information from innovator Doxorubicin HCl by Hospira Monograph, Doxorubicin HCl by Hospira MSDS, Doxorubicin HCl by Hospira FDA label

FAQ

What is Doxorubicin HCl by Hospira used for?

Doxorubicin HCl by Hospira is used in combination with other medications to treat certain types of bladder, breast, lung, stomach, and ovarian cancer; Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (cancer that begins in the cells of the immune system); and certain types of leukemia (cancer of the white blood cells). It is often used together with other chemotherapy agents.

How safe is Doxorubicin HCl by Hospira?

Doxorubicin HCl by Hospira effects help patients achieve lengthy and good quality of life remission and survival times for many types of malignancies. Although Doxorubicin HCl by Hospira poses significant risks in administration and toxicity, it is one of the most effective chemotherapeutic agents in veterinary medicine.

What is the mechanism of action of Doxorubicin HCl by Hospira?

What are the common side effects of Doxorubicin HCl by Hospira?

Common side effects of Doxorubicin HCl by Hospira are include:

Atazanavir
Boceprevir
Cobicistat
Lopinavir
Measles Virus Vaccine, Live
Mumps Virus Vaccine, Live
Nelfinavir
Rotavirus Vaccine, Live
Rubella Virus Vaccine, Live
Saquinavir
Tasonermin
Telaprevir
Varicella Virus Vaccine, Live
Zoster Vaccine, Live

Is Doxorubicin HCl by Hospira safe during pregnancy?

Cyclophosphamide and Doxorubicin HCl by Hospira are pregnancy category D agents; however, potential benefits may warrant treatment with these agents during pregnancy under special circumstances.

Is Doxorubicin HCl by Hospira safe during breastfeeding?

Most sources consider breastfeeding to be contraindicated during maternal antineoplastic Doxorubicin HCl by Hospira therapy, especially anthracyclines such as Doxorubicin HCl by Hospira.

Can I drink alcohol with Doxorubicin HCl by Hospira?

The drinking of alcohol does not appear to affect the safety or usefulness of pegylated liposomal Doxorubicin HCl by Hospira.

How often do I take Doxorubicin HCl by Hospira?

Doxorubicin HCl by Hospira is usually given once every 21 to 28 days.

How long does Doxorubicin HCl by Hospira take to work?

Doxorubicin HCl by Hospira is a light red liquid that you have through a drip (infusion) into your bloodstream. It usually takes between 30 to 90 minutes each time you have it.

How long is Doxorubicin HCl by Hospira treatment?

You usually have liposomal Doxorubicin HCl by Hospira every 2 to 4 weeks. Your treatment plan will depend on the type of cancer you have.

What is the half life of Doxorubicin HCl by Hospira?

The initial distribution half-life of approximately 5 minutes suggests rapid tissue uptake of doxorubicin, while its slow elimination from tissues is reflected by a terminal half-life of 20 to 48 hours.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your Doxorubicin HCl by Hospira injection.

What happens if I overdose?

Since this medication is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

Who should not take Doxorubicin HCl by Hospira?

You should not use Doxorubicin HCl by Hospira if you have severe liver disease, severe heart problems, very low blood cell counts caused by prior chemotherapy, or if you recently had a heart attack. You should not use this medicine if you are allergic to Doxorubicin HCl by Hospira or similar medications or if you have:

very low blood cell counts caused by chemotherapy you received in the past; severe liver disease; severe heart problems; or if you have recently had a heart attack.

Will Doxorubicin HCl by Hospira affect my fertility?

We know that certain chemotherapy medicines are more likely than others to cause infertility, including Doxorubicin HCl by Hospira.

Can Doxorubicin HCl by Hospira affects my heart?

Doxorubicin HCl by Hospira is well recognized that Doxorubicin HCl by Hospira may cause damage to the heart in some individuals.

Can Doxorubicin HCl by Hospira affect my kidneys?

Researches have shown that Doxorubicin HCl by Hospira chemotherapy could generate severe tissue injury in heart and kidney and the symptoms of renal damage like hematuresis and proteinuria are especially evident.

Can Doxorubicin HCl by Hospira affects my liver?

While hepatotoxicity from Doxorubicin HCl by Hospira, epirubicin or idarubicin may be rare, it is likely due to direct toxic injury to the liver. Doxorubicin HCl by Hospira and its analogues are metabolized in the liver via microsomal enzymes, and production of a toxic or immunogenic intermediate may trigger liver injury.

What happen If I stop taking Doxorubicin HCl by Hospira?

If you decide to stop chemotherapy, be sure you're still getting relief from symptoms such as pain, constipation, and nausea. This is called palliative care, and it's meant to improve your quality of life